You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 8, August 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Choroidal Neovascularization
 •Macular Degeneration
 •Retinal/ Chorioretinal Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Choroidal Infarction Following Photodynamic Therapy With Verteporfin

Arch Ophthalmol. 2005;123:1149-1153.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In recent years, photodynamic therapy (PDT) using verteporfin has emerged as an important method for treating certain subtypes of choroidal neovascularization (CNV) in age-related macular degeneration.1 Despite the significant beneficial effects, a 4% risk of acute severe vision decrease has been reported for patients undergoing PDT with verteporfin.2 An initial thermally enhanced photochemical impact on the macula appears to induce changes in the choriocapillaris to arrest the progression of the neovascularized complex without significant permanent damage to the choriocapillaris, retinal pigment epithelium, and photoreceptors.3 There have been a few cases, however, of transient choroidal ischemia, where normal choroidal vessels have shown evidence of transient delay. The ischemic change in these eyes evolves without clinical evidence of permanent damage. This is a report of a choroidal infarction observed in the treatment of CNV in age-related macular degeneration using standard methods of PDT with verteporfin.

Report of Cases

Case 1. In an otherwise healthy . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION
Christina M. Klais, MD; Michael D. Ober, MD; K. Bailey Freund, MD; Leonard H. Ginsburg, MD; Alan Luckie, MD; Martine Mauget-Faÿsse, MD; Gabriel Coscas, MD; Nicole E. Gross, MD; Lawrence A. Yannuzzi, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Severe Retinal Vascular Infarction After Photodynamic Therapy With Verteporfin Using the Standard Protocol
Koizumi and Hatanaka
Arch Ophthalmol 2010;128:259-262.
FULL TEXT  

Combination of Photodynamic Therapy and Intraocular Triamcinolone for Exudative Age-Related Macular Degeneration and Long-Term Chorioretinal Macular Atrophy
Piermarocchi et al.
Arch Ophthalmol 2008;126:1367-1374.
ABSTRACT | FULL TEXT  

Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases
Kang et al.
Br J Ophthalmol 2007;91:1602-1606.
ABSTRACT | FULL TEXT  

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study
Chan et al.
Br J Ophthalmol 2007;91:174-179.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.